SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 31.13 |
| Enterprise Value ($M) | 32.61 |
| Book Value ($M) | 3.87 |
| Book Value / Share | 1.15 |
| Price / Book | 8.05 |
| NCAV ($M) | -3.99 |
| NCAV / Share | -1.19 |
| Price / NCAV | -7.80 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.86 |
| Return on Assets (ROA) | -1.04 |
| Return on Equity (ROE) | -2.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.23 |
| Current Ratio | 0.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.05 |
| Assets | 8.91 |
| Liabilities | 5.04 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -10.05 |
| Net Income | -9.81 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -6.65 |
| Cash from Investing | 0.00 |
| Cash from Financing | 5.71 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -46.15 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 32,067 | 67,060 | 47.82 | |
| 7,497 | 24,726 | 30.32 | |
| 1,333 | 4,420 | 30.16 | |
| 15,234 | 43,929 | 34.68 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CNSP – CNS Pharmaceuticals, Inc. | CNTX – Context Therapeutics Inc. |
| COCP – Cocrystal Pharma, Inc. | CORT – Corcept Therapeutics Incorporated |
| COYA – Coya Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io